AbCellera is a technology company that searches, decodes, and analyses natural immune systems to identify antibodies that its partners can develop into drugs aimed at preventing and treating disease. The company has developed advanced antibody discovery and development technologies, positioning itself as a key supplier to the pharmaceutical industry.

Services include:
– Biologics
– Antibody discovery
– Drug development
– Cell line development
– Research and development support

AbCellera is committed to advancing the biopharmaceutical landscape through its innovative technologies and tailored services. For more information, please visit abcellera.com.